With more research, there is a potential for vaccines to have both adaptive and trained immunity to fight different diseases.

With more research, there is a potential for vaccines to have both adaptive and trained immunity to fight different diseases.
A new in situ, personalized cancer vaccine captures molecules from growing tumors to activate the body’s immune cells against them.
Living microrobots made from algae were weaponized to help fight tumors by improving the effectiveness of cancer therapies.
Dehumidifying pendants, the origins of olfactory neurons, microspectrometers, and transforming cancer agents.
A fragile cancer immunotherapy agent “cGAMP” is delivered to tumor sites using tiny bubbles that protect it until it reaches its destination.
The new sensors reliably and uniformly detected molecular signals, and their performance remained intact when tested again after two and a half months.
Polymer-based broad spectrum antivirals show activity against Zika, Ebola, HIV-1, the Herpes simplex virus, and now, SARS-CoV-2.
Using nanoparticles fitted with ACE2 receptors, researchers hope to lure SARS-CoV-2 away from healthy cells to inhibit the virus and treat infection.
Researchers in Shanghai report a potential therapeutic based on Prussian blue to tackle Parkinson’s disease.
Chemical engineer and STEM advocate Lola Eniola-Adefeso deciphers components of the blood and designs therapeutic particles to help treat disease.